Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Invesco DB Agriculture Fund (DBA) vs Johnson & Johnson (JNJ) Price & Performance

Invesco DB Agriculture FundTrade
Johnson & JohnsonTrade

Price performance (Past 24H)

Key statistics

Invesco DB Agriculture Fund vs Johnson & Johnson — how do they compare? Invesco DB Agriculture Fund trades at $27.61, while Johnson & Johnson trades at $260.51 (market cap $626.09B). The key difference: Johnson & Johnson pays a 2.06% dividend while Invesco DB Agriculture Fund pays none, and Johnson & Johnson is trading nearer its 52-week high, Invesco DB Agriculture Fund nearer its low. Which is the better fit depends on your goals.

DBAJNJ
52-Week High
$28.73$267.24
52-Week Low
$25.44$172.78
Market Cap
$626.09B
Volume
6,156,228
Sector
Health
Enterprise Value
$654.37B
Dividend Yield
2.06%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Invesco DB Agriculture Fund

DBA trades at $27.84, up 0.07% today, with a bullish technical signal from moving averages. The ETF has gained 5% over the past month, outperforming the S&P 500, as agricultural commodities benefit from supply concerns and strong demand. Recent news highlights consolidation near all-time highs, supported by a 3.25% yield and diversified exposure to agricultural futures.

The outlook remains positive due to geopolitical tensions and China's crop purchase pledges, but risks include commodity volatility and management fees. Investors should weigh the ETF's momentum against potential price swings in underlying futures contracts.

Johnson & Johnson

Johnson & Johnson (JNJ) trades at $260.88, down 0.36% today, with a bullish technical signal supported by moving averages. The stock shows strong profitability with a net margin of 21.48% and ROE of 25.74%, though valuations like a P/E of 30.14 appear elevated. Recent earnings beat expectations in Q1 and Q2 2026, and the company maintains a 64-year dividend growth streak, with analyst consensus leaning bullish.

Outlook remains positive with a consensus price target of $284.50, offering potential upside, but risks include legal challenges and high debt-to-asset ratio of 24.06% in 2025. Investors benefit from steady dividends and defensive positioning in healthcare, though valuation multiples may limit near-term gains amid economic uncertainty.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Invesco DB Agriculture Fund

The index, which is comprised of one or more underlying commodities ("index commodities"), is intended to reflect the agricultural sector. The fund pursues its investment objective by investing in a portfolio of exchange-traded futures.

Read more on DBA

About Johnson & Johnson

Johnson & Johnson manufactures health care products and provides related services for the consumer, pharmaceutical, and medical devices and diagnostics markets. The Company sells products such as skin and hair care products, acetaminophen products, pharmaceuticals, diagnostic equipment, and surgical equipment in countries located around the world.

Read more on JNJ